Northwestern Mutual Wealth Management
CLRB icon

Northwestern Mutual Wealth Management’s Cellectar Biosciences CLRB Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-67
Closed -$13K – 3140
2021
Q4 		$13K Buy
+67
New +$16.1K ﹤0.01% 2471
2017
Q4 		– Hold
0
– -$1K – 2314
2017
Q3 		– Hold
0
– – – 2045
2017
Q2 		– Hold
0
– – – 1929
2017
Q1 		– Hold
0
– – – 1902
2016
Q4 		– Hold
0
– – – 2351
2016
Q3 		– Hold
0
– -$1K – 414
2016
Q2 		– Hold
0
– – – 1925
2016
Q1 		– Hold
0
– – – 1981

Other funds holding CLRB

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northwestern Mutual Wealth Management's CLRB Position: Q1 2022 in Review

Northwestern Mutual Wealth Management sold out of Cellectar Biosciences (CLRB) in Q1 2022, closing a stake of 67 shares — an estimated $13K sold.

Northwestern Mutual Wealth Management first reported a position in CLRB in Q4 2021 and held it in 1 quarter. The position peaked at $13K in Q4 2021. 30 funds tracked by Wall St. Rank hold CLRB as of Q1 2022.

  • Northwestern Mutual Wealth Management reported no remaining Cellectar Biosciences position as of Q1 2022 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 67 Cellectar Biosciences shares in Q1 2022, an estimated $13K.
  • Northwestern Mutual Wealth Management first reported a position in Cellectar Biosciences in Q4 2021 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's Cellectar Biosciences position peaked at $13K in Q4 2021.
  • 30 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q1 2022.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2022, filed 9 May 2022.